P209 Long-term effectiveness and safety of vedolizumab in patients with ulcerative colitis: 5-year cumulative exposure of GEMINI 1 completers rolling into the GEMINI open-label extension study
| Autor: | Brian G. Feagan, Silvio Danese, Alexandra James, G. D'Haens, I. Shafran, Parnia Geransar, David T. Rubin, J.-F. Colombel, W J Sandborn, Bruce E. Sands, Severine Vermeire, Arthur Kaser, Sharon O'Byrne, Javaria Mona Khalid, Edward V. Loftus, Remo Panaccione, Arpeat Kaviya |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty business.industry Extension study Gastroenterology Cumulative Exposure General Medicine medicine.disease Interim analysis Inflammatory bowel disease Ulcerative colitis Surgery Vedolizumab 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Internal medicine medicine 030211 gastroenterology & hepatology In patient Open label business medicine.drug |
| Zdroj: | Journal of Crohn's and Colitis. 11:S182-S183 |
| ISSN: | 1876-4479 1873-9946 |
| DOI: | 10.1093/ecco-jcc/jjx002.334 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|